Clinical trial
A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding
NCT00129818 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00129818 |
|---|---|
| Title | A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding |
| Official title | A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Genital Herpes |
| Intervention type | Drug |
| Interventions | Famciclovir |
| Start date | Jul 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Aug 12, 2005 |
| Last update posted | Apr 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: